![]() |
|
| Discuss Building Up A Portfolio At A 7000 Level at the Equities within the Traderji.com - Discussion forum for Stocks Commodities & Forex; Originally Posted by ssnkumar Hello Supratik, We have been holding HEG for past few months, ... |
|
|||||||
| Notices |
| Equities Discuss & analyse stock market news, views, trends and your favourite stocks here. |
![]() |
|
|
Thread Tools |
| Sponsored Links |
|
#981
|
|||
|
|||
|
Quote:
Narendra, I think the downside would be limited in this. It has a stable point at 155 – it should not break that. I think we can use that as a SL. Technically it looks a good script but sometimes it is not prominent in the market. I think the appreciation in the market would come after some days. I think we can sell it now (I believe we are not in a loss anyway) and once the activity starts, we can take position. Thanks and Regards Supratik |
| Sponsored Links |
|
#982
|
|||
|
|||
|
Quote:
Please let me know when we can rebuy it. Also, any new tips? Regards, Narendra |
|
#983
|
|||
|
|||
|
Quote:
This was recommended by Outlook Money and I have posted the same in the forum. I think telecom is one sector which should do well in the next few years. I have taken position in the script myself. Thanks and Regards Supratik |
|
#984
|
|||
|
|||
|
Quote:
I sold just before the May06 crash and again bought it last month. -Narendra |
|
#985
|
|||
|
|||
|
Updates on Deccan Chronicle
Deccan Chronicle Q3 earnings surge 52.2% Source: IRIS (19 January 2007) Deccan Chronicle (Q, N,C,F)* Holdings said Friday that the company`s earnings rose 52.20% for the quarter ended December 2006. During the quarter, the company`s net profit increased to Rs. 484.40 million as compared with a profit of Rs. 318.26 million in the corresponding quarter the previous year. The sales for the quarter rose 44.03% to Rs. 1463.9 million compared with Rs 1016.38 million, a year ago. The total income for the quarter rose 39.33% to Rs 1516.20 million compared with Rs 1088.19 million, a year ago. The earning per share for the quarter jumped to Rs 11.34 compared with Rs 7.72 in the year ago period. The shares of company closed down Rs 2.25, or 0.26% at Rs 857.70 at the NSE. Total volume of shares traded was 69,956 (12.27 p.m., Friday). Recommend a hold on this counter. It should foray into Kerala - market sources and if this is true we shall buy into the couter. Thanks and Regards Supratik |
|
#986
|
|||
|
|||
|
Hi All,
fyi Dr Reddy's Q3 net zooms 200% to Rs 188cr Our Web Bureau / Mumbai January 22, 2007 Dr Reddys Laboratories (DRL) today reported a 200% increase in consolidated net profit at Rs 187.94 crore for the third quarter ended December 31, 2006 under US GAAP as against Rs 62.83 crore in Q3FY06. According to a release issued by the company to the BSE today, total income moved up 160% to Rs 1,543.42 crore from Rs 592.63 crore in Q3FY06. Satish Reddy, vice chairman, Dr. Reddy's Labs, said international revenue zoomed over 200% in Q3FY07. G V Prasad, CEO, Dr. Reddy's Labs, said: "Fiscal 2007 has been a truly extraordinary year for Dr. Reddy’s in many ways. For the first time in the history of Dr. Reddy’s, we have crossed $1 billion in revenue." Thanks and Regards Supratik |
|
#987
|
|||
|
|||
|
Hi All,
NIIT on huge volatility. Intraday and short term traders can track this. Thanks and Regards Supratik |
|
#988
|
|||
|
|||
|
Hi All,
The next tip is on IPCA Lab. CMP 620. The target will not be set currently. Buy in low volumes – it is highly volatile and we may need to buy again at lower levels (to average it out). This tip is little on the higher risk side. Results update: Related Links Ipca Laboratories Limited Ipca Labs net up 12.05 times in Dec`06 qtr Source: IRIS (23 January 2007) Ipca Labs (Q, N,C,F)* reported a substantial jump of 12.05 times in net profits to Rs. 348.4 million for quarter ending December 2006 as compared to Rs. 26.7 million for quarter ended December 2005. Net sales for the quarter rose 34.61% to Rs. 2324.9 million compared with the corresponding quarter, a year ago. Total Income (net of excise) has increased 33.48% to Rs 2330.5 million as against Rs 1745.9 million in same quarter last year. Earnings per share for the quarter rose to Rs 13.94 from Rs 1.07 last year. Ipca is a Mumbai based fast growing fully integrated pharmaceutical company engaged in the manufacturing and marketing of a range of pharmaceuticals world over with a strong thrust on exports. On Jan. 2, 2007, the Ipca - Ranbaxy alliance received USFDA marketing approval for Atenolol Tablets. It is one of the largest producers in the world of API Atenolol and holds its DMFs in various countries. Ipca is also marketing formulations of Atenolol in various markets such as CIS, Asia, Africa and Europe. This approval will further strengthen Ipca`s global market share of this product. Will this be Divi's Lab????? Thanks and Regards Supratik Last edited by supratik; 23rd January 2007 at 09:09 PM. |
|
#989
|
|||
|
|||
|
Hi All,
Heard on the Streets call on S…..P – guess it – will post it tomorrow – stress your brain for the night ![]() Please note: Heard on the streets call is only a punter pick and may not be on the fundamental story of the company. Thanks and Regards Supratik |
|
#990
|
|||
|
|||
|
Shoppers Stop?
Technically I would put it right now in almost Under-bought categrory. |
| Sponsored Links |
|
|
![]() |
| Bookmarks |
| Thread Tools | |
|
|
Similar Threads for: Building Up A Portfolio At A 7000 Level
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Put Options to protect your stock portfolio | Mohan | Options | 10 | 23rd June 2008 03:16 PM |
Indemnity, Disclaimer & Disclosure
Notice:
• By visiting Traderji.com you indicate your acceptance of our Forum
Rules Disclaimer & Disclosure and indemnify Traderji.com, its
associates and related parties of all claims howsoever resulting from
the usage of the forum.
• Disclaimer: Trading or investing in stocks & commodities
is a high risk activity. Any action you choose to take in the markets
is totally your own responsibility. Traderji.com will not be liable for
any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.
• Disclosure: The information in this forum is neither an offer to sell nor solicitation to buy any of the securities mentioned herein.
The writers may or may not be trading in the securities mentioned.
• All names or products mentioned are trademarks or registered trademarks of their respective owners.
General Content Disclaimer Notice:
In light of our policy of encouraging candid, open exchanges of views and the rapid distribution of information originating from many sources, Traderji.com cannot determine the accuracy of information that may be uploaded to the forum. Opinions, advice and all other information expressed by participants in discussions are those of the author. You rely on such information at your own risk. You are urged to seek professional advice for specific, individual situations and not rely solely on advice or opinions given in the discussions. Since Traderji.com is an open and free discussion forum, any comments made by members of this forum in their posts reflect their own views and not of the owner or administrator of Traderji.com. Thus the owner/administrator indemnify themselves of all claims whatsoever and will not be liable or responsible for any members comments/views in this forum Traderji.com. If you find any objectionable or offensive posts made by members of this forum which you would like to bring to our notice for removal then please Contact Us.